{"id":43437,"date":"2025-10-15T16:39:13","date_gmt":"2025-10-15T08:39:13","guid":{"rendered":"https:\/\/flcube.com\/?p=43437"},"modified":"2025-10-15T16:39:14","modified_gmt":"2025-10-15T08:39:14","slug":"genscripts-probio-secures-rmb-479-7-m-license-payment-for-lm%e2%80%91299-boosting-sinobiopharmaceuticals-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43437","title":{"rendered":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">GenScript Biotech Corporation (<a href=\"https:\/\/www.google.com\/finance\/quote\/1548:HKG\">HKG: 1548<\/a>) today announced that its Contract\u2011Development\u2011and\u2011Manufacturing\u2011Organization (CDMO) platform, <strong>ProBio<\/strong>, received a <strong>RMB\u202f479.7\u202fmillion<\/strong> (\u2248\u202f$67.5\u202fmillion) license payment under a PD\u20111 monoclonal antibody licensing agreement with <strong>LaNova Medicines<\/strong> (now a subsidiary of <strong>Sino Biopharmaceutical<\/strong>). The payment brings ProBio\u2019s cumulative license receipts to <strong>RMB\u202f2\u202fbillion<\/strong> (\u2248\u202f$283.6\u202fmillion) since the original agreement.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-transaction-highlights\">Key Transaction Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>License Recipient<\/strong><\/td><td>ProBio, GenScript\u2019s CDMO arm<\/td><\/tr><tr><td><strong>Licensee<\/strong><\/td><td>LaNova\u202fMedicines \u2013 acquired by Sino\u202fBiopharmaceutical (HKEX:\u202f1177)<\/td><\/tr><tr><td><strong>License Payment (Oct\u202f14\u202f2025)<\/strong><\/td><td>RMB\u202f479.7\u202fmillion (\u2248\u202f$67.5\u202fmillion)<\/td><\/tr><tr><td><strong>Cumulative License Receipts<\/strong><\/td><td>RMB\u202f2\u202fbillion (\u2248\u202f$283.6\u202fmillion)<\/td><\/tr><tr><td><strong>Underlying Asset<\/strong><\/td><td>PD\u20111\/VEGF bispecific antibody <strong>LM\u2011299<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-broader-context\">Broader Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Merck &amp; Co. Collaboration<\/strong> \u2013 In November\u202f2024, <strong>Merck &amp; Co. (MSD)<\/strong> and LaNova signed a <strong>$3.3\u202fbillion<\/strong> partnership. MSD will hold exclusive global rights to develop, manufacture, and commercialise LaNova\u2019s <strong>LM\u2011299<\/strong>. LaNova will receive an upfront payment of <strong>$588\u202fmillion<\/strong> and up to <strong>$2.7\u202fbillion<\/strong> in milestone payments.<\/li>\n\n\n\n<li><strong>ProBio\u2019s Financial Share<\/strong> \u2013 Under the revised agreement, ProBio is entitled to:<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>40\u202f%<\/strong> of the upfront payment and <strong>25\u202f%<\/strong> of milestone payments from any re\u2011licensing during the IND\u2011to\u2011Phase\u202fI window.<\/li>\n\n\n\n<li><strong>25\u202f%<\/strong> of the royalties earned by LaNova from commercial sales of LM\u2011299.<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sino\u202fBiopharmaceutical Acquisition<\/strong> \u2013 In July\u202f2025, Sino\u202fBiopharmaceutical acquired <strong>95.09\u202f%<\/strong> of LaNova\u2019s equity for <strong>$950.92\u202fmillion<\/strong>, solidifying its stake in the LM\u2011299 pipeline.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The latest payment underscores the commercial traction of GenScript\u2019s ProBio platform and the robust pipeline of LM\u2011299. For Sino\u202fBiopharmaceutical, the deal enhances its strategic portfolio in oncology and immunology, while providing a significant revenue stream from a high\u2011profile bispecific antibody that leverages ProBio\u2019s PD\u20111 expertise.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GenScript Biotech Corporation (HKG: 1548) today announced that its Contract\u2011Development\u2011and\u2011Manufacturing\u2011Organization (CDMO) platform, ProBio, received a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43439,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[521,872,1376,2675,176,719,313],"class_list":["post-43437","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-genscript-biotech","tag-hkg-1548","tag-lanova-medicines","tag-merck-sharp-dohme","tag-msd","tag-probio","tag-sino-biopharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43437\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43437\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T08:39:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-15T08:39:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio\",\"datePublished\":\"2025-10-15T08:39:13+00:00\",\"dateModified\":\"2025-10-15T08:39:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437\"},\"wordCount\":292,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1511.webp\",\"keywords\":[\"Genscript Biotech\",\"HKG: 1548\",\"LaNova Medicines\",\"Merck Sharp &amp; Dohme\",\"MSD\",\"ProBio\",\"Sino Biopharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43437#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43437\",\"name\":\"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1511.webp\",\"datePublished\":\"2025-10-15T08:39:13+00:00\",\"dateModified\":\"2025-10-15T08:39:14+00:00\",\"description\":\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43437\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1511.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1511.webp\",\"width\":1080,\"height\":608,\"caption\":\"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43437#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43437","og_locale":"en_US","og_type":"article","og_title":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=43437","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-15T08:39:13+00:00","article_modified_time":"2025-10-15T08:39:14+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43437#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43437"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio","datePublished":"2025-10-15T08:39:13+00:00","dateModified":"2025-10-15T08:39:14+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43437"},"wordCount":292,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43437#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","keywords":["Genscript Biotech","HKG: 1548","LaNova Medicines","Merck Sharp &amp; Dohme","MSD","ProBio","Sino Biopharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43437#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43437","url":"https:\/\/flcube.com\/?p=43437","name":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43437#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43437#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","datePublished":"2025-10-15T08:39:13+00:00","dateModified":"2025-10-15T08:39:14+00:00","description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43437#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43437"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43437#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","width":1080,"height":608,"caption":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43437#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"GenScript\u2019s ProBio Secures RMB\u202f479.7\u202fM License Payment for LM\u2011299, Boosting SinoBiopharmaceutical\u2019s Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1511.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43437"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43437\/revisions"}],"predecessor-version":[{"id":43440,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43437\/revisions\/43440"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43439"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}